Skip to content

Drug interactions

Sotorasib + Topotecan

Severity: Moderate

Sotorasib and Topotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib is a P-gp inhibitor and would be expected to increase, rather than decrease, exposure to P-gp substrates such as topotecan. This could increase topotecan toxicity, particularly myelosuppression.

What this interaction means in plain words

Sotorasib and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sotorasib belongs to Oncology; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Sotorasib inhibits intestinal and cellular P-gp efflux of topotecan, predicted to raise its systemic exposure.

What to do

Avoid oral topotecan with sotorasib where possible; with IV topotecan, monitor blood counts and adjust the dose for toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sotorasib and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sotorasib with Topotecan?

MediHelp rates the interaction as moderate. Sotorasib and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib is a P-gp inhibitor and would be expected to increase, rather than decrease, exposure to P-gp substrates such as topotecan. This could increase topotecan toxicity, particularly myelosuppression.

How serious is the interaction between Sotorasib and Topotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid oral topotecan with sotorasib where possible; with IV topotecan, monitor blood counts and adjust the dose for toxicity.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in